Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2026

Go back to Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2026
(NASDAQ: GMAB) Delayed: 39.57 +0.50 (1.28%)
Previous Close $39.07    52 Week High $ 
Open $39.08    52 Week Low $ 
Day High $39.66    P/E N/A 
Day Low $39.05    EPS $ 
Volume 3,106,117